Stock Events

Stock Events

InnoCare Pharma Limited 

¥26.65
5
-¥0.15-0.56% Thursday 06:55

Statistics

Day High
27.28
Day Low
26.59
52W High
33.51
52W Low
19.88
Volume
8,537,831
Avg. Volume
-
Mkt Cap
46.97B
P/E Ratio
72.68
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23AprExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
-0.02
0.01
0.03
0.06
Expected EPS
N/A
Actual EPS
0.059357530799999995

Financials

-43.65%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
2.02BRevenue
-881.27MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 688428.SHG. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zai Lab Limited
ZLAB
Mkt Cap2.42B
Zai Lab Limited operates in the biopharmaceutical sector focusing on oncology and autoimmune disorders, similar to InnoCare's therapeutic areas.
HUTCHMED (China) Limited
HCM
Mkt Cap2.29B
Hutchison China MediTech Limited, known as Chi-Med, focuses on discovering, developing, and commercializing cancer and immunological drugs.
CytomX Therapeutics
CTMX
Mkt Cap903.62M
CytomX Therapeutics, Inc. specializes in antibody therapeutics for cancer similar to InnoCare's focus on oncology treatments.
Karyopharm Therapeutics
KPTI
Mkt Cap209.65M
Karyopharm Therapeutics Inc. is involved in the development of drugs for the treatment of cancer, competing in the same therapeutic area as InnoCare.
Xencor
XNCR
Mkt Cap990.34M
Xencor Inc. develops engineered monoclonal antibodies for the treatment of cancer, autoimmune diseases, and asthma, overlapping with InnoCare's market.
Macrogenics
MGNX
Mkt Cap203.39M
MacroGenics, Inc. focuses on discovering and developing antibody-based therapeutics for the treatment of cancer, similar to InnoCare's products.
Allogene Therapeutics
ALLO
Mkt Cap739.55M
Allogene Therapeutics, Inc. works on allogeneic CAR T therapies for cancer, a direct competitor in innovative cancer treatments.

About

InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China. The company develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder. It also developing ICP-B02 to treat CD20+B-cell malignancies; ICP-B05 to treat hemato-oncology; ICP-248 to treat chronic lymphocytic leukemia; ICP-332 to treat atopic dermatitis; ICP-488 to treat psoriasis; ICP-538 to treat autoimmune diseases; zurletrectinib (ICP-723) to treat neurotrophic tyrosine receptor kinase fusion positive cancers; ICP-189 to treat non-small cell lung cancer; and ICP-B05 to treat solid tumor. InnoCare Pharma Limited was incorporated in 2015 and is headquartered in Beijing, China.
Show more...
CEO
Dr. Jisong Cui Ph.D.
Employees
1176
Country
China
ISIN
CNE100005P56

Listings

HK
HK
9969.HK
MU
DE
33C.MU
STU
DE
33C.STU
F
DE
33C.F

0 Comments

Share your thoughts

FAQ

What is InnoCare Pharma Limited stock price today?▼
The current price of 688428.SHG is ¥26.65 CNY — it has decreased by -0.56% in the past 24 hours. Watch InnoCare Pharma Limited stock price performance more closely on the chart.
What is InnoCare Pharma Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange InnoCare Pharma Limited stocks are traded under the ticker 688428.SHG.
Is InnoCare Pharma Limited stock price growing?▼
688428.SHG stock has fallen by -0.56% compared to the previous week, the month change is a -9.29% fall, over the last year InnoCare Pharma Limited has showed a +25.59% increase.
What is InnoCare Pharma Limited market cap?▼
Today InnoCare Pharma Limited has the market capitalization of 46.97B
When is the next InnoCare Pharma Limited earnings date?▼
InnoCare Pharma Limited is going to release the next earnings report on August 25, 2026.
What were InnoCare Pharma Limited earnings last quarter?▼
688428.SHG earnings for the last quarter are 0.06 CNY per share, whereas the estimation was N/A CNY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A CNY per share.
What is InnoCare Pharma Limited revenue for the last year?▼
InnoCare Pharma Limited revenue for the last year amounts to 2.02B CNY.
What is InnoCare Pharma Limited net income for the last year?▼
688428.SHG net income for the last year is -881.27M CNY.
How many employees does InnoCare Pharma Limited have?▼
As of May 06, 2026, the company has 1,176 employees.
In which sector is InnoCare Pharma Limited located?▼
InnoCare Pharma Limited operates in the Health & Wellness sector.
When did InnoCare Pharma Limited complete a stock split?▼
InnoCare Pharma Limited has not had any recent stock splits.
Where is InnoCare Pharma Limited headquartered?▼
InnoCare Pharma Limited is headquartered in Beijing, China.